Kristine Torjesen, MD, MPH

Associate Director, Science Facilitation and Project Director, OPTIONS Consortium

Areas of expertise

  • Pediatrics
  • Reproductive health
  • Quality improvement
  • Implementation science
  • Clinical trials
  • Health systems strengthening
  • Maternal neonatal child health

Projects & Resources

  • The OPTIONS Consortium represents an international, multidisciplinary partnership of global, regional and country experts across the antiretroviral-based HIV prevention research-to-rollout continuum. The consortium’s goal is to provide targeted support to expedite and sustain access to ARV-based HIV prevention products in countries and among populations where most needed.

  • FHI 360 works with partners in Africa, Asia, Latin America and the United States to assess the safety, acceptability and effectiveness of potential microbicides in preventing HIV and other sexually transmitted infections.

Published Research

  • Perceptions and experiences with the VOICE adherence strengthening program (VASP) in the MTN-003 trial
    van der Straten A, Mayo A, Brown ER, Amico KR, Cheng H, Laborde N, Marrazzo J, Torjesen K.
    AIDS Behav 2014 Nov; epub ahead of print. [Journal Impact Factor: 3.312]

    The vaginal and oral interventions to control the epidemic (VOICE) adherence strengthening program (VASP) revealed challenges to mid-study changes in the adherence support approach in a large multisite clinical trial. The research recommended that future adherence support packages: 1) use an integrated, multidisciplinary approach from study start; 2) use multiple modalities for participant engagement to best fit the local culture; and 3) document the fidelity of implementation so the potential impact of adherence support interventions can be assessed.

Explore More Related to Kristine Torjesen, MD, MPH